Antihypertensive therapy should be administered to individuals with hypertension and PAD to scale back the chance of MI, stroke, heart failure, and cardiovascular Demise.9 Angiotensin-converting enzyme inhibitors directly inhibit the atherosclerotic method and strengthen vascular endothelial purpose, independent in their antihypertensive outcomes.3